Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 27Lymphoma, Non-Hodgkin 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 25Lymphoma, Follicular 25Lymphoma, B-Cell, Marginal Zone 25Leukemia, Lymphocytic, Chronic, B-Cell 25Lymphoma, Mantle-Cell 24Lymphoma, Large-Cell, Immunoblastic 24Lymphoma, Large B-Cell, Diffuse 24Burkitt Lymphoma 24Sezary Syndrome 23Mycosis Fungoides 22Leukemia, Myeloid, Acute 22Hodgkin Disease 22Multiple Myeloma 21Leukemia, Myeloid, Chronic-Phase 20Congenital Abnormalities 18Leukemia, Myeloid, Accelerated Phase 17Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 16Lymphoma, Large-Cell, Anaplastic 16Dendritic Cell Sarcoma, Interdigitating 16Recurrence 15Myeloproliferative Disorders 15Lymphoma 15Immunoblastic Lymphadenopathy 15Leukemia, Myelomonocytic, Chronic 14Leukemia 14Waldenstrom Macroglobulinemia 13Lymphoma, Extranodal NK-T-Cell 13Blast Crisis 13

Interventions

Lymphatic Irradiation 1Cyclosporine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycoses × Cyclosporine × Dermatologic × Clear all
NCT00896493 2023-05-11

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Stanford University

Phase 2 Completed
38 enrolled 21 charts
DermatologicLymphoid

Lymphoma, Non-Hodgkin, Mycoses, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡